These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4980954)

  • 1. [Rifampicin inhibitory titer in wild strains of Mycobacterium and Rifampicin serum concentrations in tuberculous patients].
    Hussels H; Schütz I
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):304-12. PubMed ID: 4980954
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey.
    Senol G; Erbaycu A; Ozsöz A
    J Chemother; 2005 Aug; 17(4):380-4. PubMed ID: 16167516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin for non-tuberculous infections?
    Grüneberg RN; Emmerson AM; Cremer AW
    Chemotherapy; 1985; 31(4):324-8. PubMed ID: 3928283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-vitro action of rifampicin on strains of tuberculous and atypical mycobacteria].
    Denis-Bottin C
    Acta Tuberc Pneumol Belg; 1972; 63(1):127-39. PubMed ID: 4631815
    [No Abstract]   [Full Text] [Related]  

  • 5. Can rifampicin use be safely extended? Evidence for non-emergence of resistant strains of Mycobacterium tuberculosis.
    Acocella G; Hamilton-Miller JM; Brumfitt W
    Lancet; 1977 Apr; 1(8014):740-2. PubMed ID: 66530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross-resistance between rifampin and rifabutin in multidrug resistant Mycobacterium tuberculosis complex strains].
    Gao L; Xiao HP; Hu ZY; Cui ZL; Lu JM; Shen XN
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):333-5. PubMed ID: 22883990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-mycobacterial activity of rifampicin].
    Gialdroni Grassi G
    G Ital Mal Torace; 1971; 25(2):77-88. PubMed ID: 5003253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacteriostatic effect of rifampicin (Rifampin) on Mycobacterium tuberculosis in vitro].
    Woźniak S; Tomaszkiewicz L; Zierski M
    Gruzlica; 1969 Nov; 37(11):983-9. PubMed ID: 4983868
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
    Cacho-Calvo J; Martín-Díaz A;
    Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
    Truffot-Pernot C; Giroir AM; Maury L; Grosset J
    Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acquired resistance of Mycobacterium tuberculosis to rifampicin].
    Fernández Guerrero ML; Posada Dueñas R; Fernández Lazcano F; Padilla Manzuco JM
    Rev Clin Esp; 1978 Sep; 150(6):357-9. PubMed ID: 103148
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin sensitivity of mycobacteria].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(1):17-28. PubMed ID: 4996680
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mode of action of rifampicin on Mycobacterium tuberculosis].
    Konno K; Oizumi K; Hayashi I; Oka S
    Kekkaku; 1972 Aug; 47(8):255-60. PubMed ID: 4634136
    [No Abstract]   [Full Text] [Related]  

  • 16. [The sensitivity of Mycobacterium tuberculosis to rifampicin and its clinical effectiveness (author's transl)].
    Chen HL
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1980 Feb; 3(2):104-5. PubMed ID: 6774865
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factors influencing the minimal inhibitory concentration of rifampicin for Mycobacterium tuberculosis (author's transl)].
    Tamura M; Yamazaki A; Tamura T; Takano S
    Kekkaku; 1973 Oct; 48(10):463-71. PubMed ID: 4205281
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
    J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of rifampicin and ethambutol on Mycobacterium tuberculosis in vitro].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1973; 51(2):56-61. PubMed ID: 4203996
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity test of M. tuberculosis against rifampicin: a short report.
    Schröder KH
    Acta Tuberc Pneumol Belg; 1969; 60(3):335-40. PubMed ID: 4984416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.